CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
PAGE: 0006
PERCENT LYMPHOCYTE DAMAGE
IN THE EXPERIMENTAL GROUP,
AND 4.6
PERCENT LYMPHOCYTE DAMAGE IN THE CONTROL GROUP.
B.
(U)
TITLE - "BIOLOGICAL REACTION OF COLON BACILLI
TO
WAIQI"
(ZQ,
NO.
2,
1990,
PP.
10,
12,
13)
- RESEARCHERS - XU WUGE,
((LIU)) WEILUN (STC 0491 4850 0243),
((LIU)) YUCHI (STC 0491 3768 3069), LI DAZHI, AND WAN SUJIAN
- AFFILIATIONS
-- BEIJING MR GENERAL HOSPITAL MEDICAL
LABORATORY, AND BEIJING MR QIGONG INSTITUTE (FIELD COMMENT -
SOURCE ERRONEOUSLY CALLED THIS
INSTITUTE "THE RESEARCH AND CLINICAL
INSTITUTE").
(FIELD COMMENT ~ RESPECTIVE ORGANIZATIONAL
AFFILIATIONS OF EACH RESEARCHER WERE NOT GIVEN
IN SOURCE.)
-
CONTENT - EXPERIMENTS WERE CONDUCTED
IN JUNE
1988 AND MARCH
1989
IN WHICH WAIQI WAS FOUND TO INHIBIT THE GROWTH OF COLON
BACILLI.
IN THE JUNE
1988 TESTS, MAXIMUM GROWTH INHIBITION WAS
OBSERVED FROM THE 3D HOUR OF BACTERIAL GROWTH THROUGH THE 12TH
HOUR;
THAT
IS, FROM THE ACTIVE PERIOD OF THE BACCILUS'
GROWTH
THROUGH
ITS PERIOD OF STABLE GROWTH.
IN THE MARCH 1989
TESTS,
THE
GROWTH OF COLON BACILLUS WAS
INHIBITED UNTIL THE 6TH HOUR OF
GROWTH,
THE BACILLUS'
ACTIVE GROWTH PERIOD.
IN ADDITION, DURING
THE EXPERIMENT,
FUSION OF MEMBRANES AND CELL WALLS OF TWO SEPARATE
CELLS WAS OBSERVED.
THE CHROMOMETER USED WAS A SERIES 1-2-3
(SIC)
MULTIPURPOSE BIOCHEMICAL ANALYZER MADE BY THE BAKER COMPANY, A
UNITED STATES FIRM.
C.
(U)
TITLE - "FREQUENCY SPECTROGRAM OF QIGONG THERAPISTS
OBSERVED USING A LASER DEVICE FOR MEASUREMENT OF CAPILLARY BLOOD
FLOW"
(ZQ,
NO.
5,
1990,
PP.
11-12)
- RESEARCHERS AND AFFILIATION - XU WUGE OF THE BEIJING MR
GENERAL HOSPITAL AND OTHERS.
- CONTENT - CHANGES
IN VOLUME OF BLOOD FLOW IN QIGONG
PRACTIONERS WERE MEASURED AT THE LAOGONG XUEWEI (STC 0525 1362 4494
0143)
(FIELD COMMENT -
THIS REFERS TO A POINT BETWEEN THE SECOND
AND THIRD METACARPAL BONE, WHICH THE TIP OF THE MIDDLE FINGER
TOUCHES WHEN THE FIST
IS CLENCHED) USING A LASER DEVICE DESIGNED TO
MEASURE CAPILLARY BLOOD FLOW.
THE DEVICE DISPLAYS
ITS MEASUREMENT
OF THE VOLUME OF CAPILLARY BLOOD FLOW
IN VOLTS.
THE AVERAGE PEAK
VOLTAGE MEASURED
IN QIGONG PRACTIONERS WAS
1,802 MILLIVOLTS,
BUT
THE AVERAGE PEAK VOLTAGE MEASURED
IN PERSONS WITH NO TRAINING
IN
QIGONG WAS
40 MILLIVOLTS.
MOREOVER, DIFFERENCES
IN VOLTAGE VARIED
WITH THE METHOD AND STYLE OF QIGONG USED
IN THE EXPERIMENTS.
THE
HIGHEST VOLTAGES WERE RECORDED
IN THOSE PERSONS WHO HAD THE MOST
EXPERIENCE PRACTICING QIGONG
.
ON AVERAGE, PEAK VOLTAGE WAS
ACHIEVED BY QIGONG PRACTIONERS
4 MINUTES AFTER THEY BEGAN
PERFORMING QIGONG .
IN NO CASE DID
IT TAKE A PRACTIONER LONGER THAN
8 MINUTES
TO REACH PEAK VOLTAGE.
D.
(U)
TITLE - "EFFECT OF QIGONG WAIQI ON ELECTROPHORESIS OF
RED BLOOD CELLS
IN PATIENTS"
(DQ,
NO.
3,
1990,
PP.
46-47)
- RESEARCHERS AND AFFILIATION
--
((FENG)) LIDA (STC 7458 3810
6671),
((LI)) YUMIN
(STC 2621 3768 2404),
((CHEN))
HAIXIN (STC 7115
3189
9515) OF THE PLA NAVY GENERAL HOSPITAL,
SHANGHAI.
CONTENT - QIQONG PRACTITIONERS APPLIED WAIQI RADIATION FOR
MINUTES
TO
IN VITRO BLOOD SAMPLES TAKEN FROM
108 PATIENTS
SUFFERING
FROM TUMORS, DIABETES, AND ISCHEMIA.
THE ELECTROPHORETIC VELOCITY
OF RED BLOOD CELLS
INCREASED UPON EXPOSURE TO WAIQI RADIATION.
IN
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
PAGE: 0007
CASES,
THE ELECTROPHORETIC VELOCITY OF THE RED BLOOD CELLS BEGAN
TO RISE AT THE BEGINNING OF THE EXPERIMENT.
ALTHOUGH THE MECHANISM
OF THE ACTION OF WAIQI ON CELL ELECTROPHORESIS
IS UNCLEAR, WAIQI
HAS PROVED EFFECTIVE IN TREATING TUMORS, DIABETES, AND ISCHEMIA.
WAIQI HAS BEEN FOUND TO BE PARTICULARLY EFFECTIVE
IN TREATING RED
BLOOD CELLS THAT HAVE SLOWER ELECTROPHORETIC VELOCITIES.
E.
(U)
TITLE - ACTION OF QIGONG WAIQI ON ARTIAL NATRIURETI
POLYPEPTIDE, UREA NITRIDE,
AND CREATININE
IN DIALYSIS PATIENTS
(QK,
NO.
3,
1990,
PP.
21-22)
- RESEARCHERS AND AFFILIATION -
((WANG)) XIUQING
(STC 3769
4423 3237),
((LIU))
CUIHONG (STC 0491 5050 4767),
((ZHAO)) YUNTAO
(STC 6392
0061 3447),
((ZHANG))
ZHAOFU
(STC
1728
2507 7450),
((ZHOU))
CHUNHUA (STC 0719
2504 5478) AND ((DONG))
BAO
(STC 5516
5508)
OF THE PLA NAVY GENERAL HOSPITAL'S DEPARTMENT OF INTERNAL
NEPHROLOGY
-
CONTENT -
TESTS WERE CONDUCTED ON 20 PATIENTS WITH CHRONIC
UREMIA RESULTING FROM RENAL FAILURE.
WHEN WAIQI THEREAPY WAS
ADMINISTERED
IN CONJUNCTION WITH CONVENTIONAL MEDICAL TREATMENT,
ARTIAL NATRIURETI POLYPETIDE AND UREA NITRIDE LEVELS
IN THE
PATIENTS'
BLOOD PLASMAS
SHOWED MARKED REDUCTIONS, AND PROSTAGLANDIN
LEVELS
INCREASED.
HOWEVER,
CREATININE AND THRONBOXANE LEVELS
SHOWED LITTLE CHANGE.
F.
(U)
TITLE - "EFFECT OF QIGONG WAIQI ON PHAGOCYTOSIS OF
IN
VITRO HUMAN LEUCOCYTES"
(QK, NO.
4,
1991,
P.
18)
- RESEARCHERS AND AFFILIATION
-- FENG LIDA,
((CHEN))
SHUYING
(STC 7115 3219 5391) AND ((WANG)) YUNSHENG (STC 3769
0061 3932)
OF
THE IMMUNOLOGY CENTER, PLA NAVY GENERAL HOSPITAL,
SHANGHAI
- CONTENT - GENERALLY, APPLIED WAIQI RADIATION WAS FOUND TO
IMPROVE PHAGOCYTOTIC FUNCTION OF IN VITRO WHITE BLOOD CELLS.
IN
OF THE 50 CASES TESTED, A 9.26 PERCENT IMPROVEMENT
IN PHAGOCYTOTIC
FUNCTION OF
IN VITRO LEUCOCYTES WAS NOTED.
IN THE OTHER 11 CASES,
IMPAIRMENT OF
IN VITRO LEUCOCYTE PHYGOCYTOTIC FUNCTION WAS
RECORDED.
G.
(U)
TITLE - "EFFECT OF QIGONG ON FUNCTION OF BLOOD
NEUTROPHILS
IN HUMANS"
(QZ, VOL.
11,
NO.
4,
1990,
PP.
171-173)
- RESEARCHER AND AFFILIATION -
((XIE))
ZHENCHUAN
(STC 6200
2182
1557)
OF THE MEDICAL LABORATORY AT THE CHENGDU MR GENERAL
HOSPITAL,
CHENGDU
( GEOCOORD :3040N/10404E)
- CONTENT -
IMMUNOLOGIC FUNCTION OF NEUTROPHILS
IN BLOOD WAS
ENHANCED AS A RESULT OF QIGONG TRAINING.
THE PHAGOCYTOTIC RATE WAS
ABOUT 24 PERCENT FOR THE EXPERIMENT'S CONTROL GROUP,
BUT THE
PHAGOCYTOTIC RATE FOR THE EXPERIMENTAL GROUP, WHICH STOOD AT ABOUT
21 PERCENT BEFORE THE EXPERIMENT, ROSE TO ABOUT 38 PERCENT ON THE
30TH DAY OF THE SUBJECTS'
QIGONG TRAINING.
THE EXPERIMENTAL GROUP
ALSO EXPERIENCED AN INCREASE
IN
ITS RATE OF POSITIVE CELL REACTION
TO NITROBLUE TETRAZOLIUM TESTS,
WHICH ROSE FROM ABOUT 32 PERCENT
BEFORE THE EXPERIMENT TO ABOUT 53 PERCENT ON THE 30TH DAY OF QIGONG
TRAINING.
THE CONTROL GROUP HAD A POSITIVE CELL REACTION RATE TO
NITROBLUE TETRAZOLIUM TESTS OF ABOUT
28 PERCENT.
H.
(U)
TITLE - "EFFECT OF QIGONG ON HEMODYNAMICS AND BLOOD
RHEOLOGY"
(QK,
NO.
4,
1990,
P.
16)
- RESEARCHERS AND AFFILIATION -
((WANG)) XIUFANG
(STC 3769
4423 5364) AND ((LUO)) FENG (STC 7482 6912),
OF THE PLA AIR FORCE
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
PAGE: 0008
HOSPITAL
IN LANZHOU
( GE0C00RD :3603N/10341E).
- CONTENT
-- AFTER UNDERGOING QIGONG TRAINING,
SIGNIFICANT
REDUCTIONS WERE NOTED
IN THE FOLLOWING HEMODYNAMIC AND BLOOD
RHEOLOGY INDICATORS -
TOTAL CARDIAC OUTPUT,
HEART RATE INDEX,
CARDIAC OUTPUT PER MINUTE, AVERAGE SYSTOLIC PRESSURE, AVERAGE
DIASTOLIC PRESSURE, AVERAGE ARTERIAL BLOOD PRESSURE,
CARDIAC
INDEX,
EFFECTIVE BLOOD VOLUME, AND PULSE RATE.
CONSPICUOUS INCREASES WERE
NOTED IN CAPILLARY SEMI-RENEWAL TIME AND AVERAGE RETENTION TIME.
QIGONG WAS FOUND TO INHIBIT THE SYMPATHETIC NERVOUS
SYSTEM,
TO
RELAX THE SKELETAL MUSCLES, AND INCREASE CAPILLARY BLOOD FLOW.
AS
A RESULT OF INCREASED CAPILLARY BLOOD FLOW, MORE OXYGEN, NUTRIENTS,
AND HORMONES REACH CELLS.
I.
(U)
OTHER RESEARCH
BEIJING MR QIGONG INSTITUTE AND BEIJING MR GENERAL HOSPITAL
CONDUCTED JOINT RESEARCH ON QIGONG WITH THE PLA ACADEMY OF MILITARY
MEDICINE.
(DQ,
NO.
3,
1990,
PP.
33-34)
3.
(U) ANIMAL AND CLINICAL APPLICATIONS OF QIGONG
A.
(U)
TITLE
--
"THE STUDY OF TRAUMATIC PARAPLEGIA
IN CANINE
MODEL TREATED BY BAGUA XUN DAO GONG (FIELD COMMENT - ONE OF THE
TYPES OF QIGONG)
(SIC)
(ZQ,
NO.
5,
1990,
PP.
9-11
- RESEARCHERS AND AFFILIATION - XU WUGE OF THE BEIJING MR
GENERAL HOSPITAL,
WAN SUJIAN OF THE BEIJING MR QIGONG INSTITUTE AND
OTHERS.
- CONTENT
--
TRADITIONALLY, QIGONG HAS BEEN USED WITH FAVORABLE
RESULTS
IN CHINA TO TREAT TRAUMATIC PARAPLEGIA.
THIS
STUDY WAS
LAUNCHED
IN EARLY 1990 TO DETERMINE THE EFFECTS OF SHORT-TERM
TREATMENT ON ACUTE CASES OF SPINAL CORD INJURY AND CHANGES
INDUCED
BY SUCH TREATMENT IN SPINAL CAPILLARY CIRCULATION.
IN THE
EXPERIMENT,
41 DOGS WERE USED AS SUBJECTS.
QIGONG WAS FOUND TO BE
EFFECTIVE
IN RESTORING NERVE FUNCTION AND SPINAL CAPILLARY
CIRCULATION,
IN HELPING THE DOGS REGAIN LOST WEIGHT, AND AS A
SEDATIVE
IN CANINE TRAUMATIC PARAPLEGIA CASES.
B.
(U)
TITLE -
"QIGONG TREATMENT OF 56 CASES OF FACIAL
PARALYSIS OF THE PERIPHERAL NERVES"
(QK,
NO.
10,
1990,
P.
25).
RESEARCHERS AND AFFILIATION
--
((REN))
GUANGPING (STC 0117
1639
1627) AND ((TANG))
CHENGPEI (STC 0781 2110
1014)
OF THE PHYSICAL
THERAPY LABORATORY,
261ST PLA HOSPITAL.
- CONTENT -
THIS TREATMENT WAS CONDUCTED BETWEEN JANUARY
1987
AND OCTOBER 1989 USING A 220 VOLT CURRENT AND THE APPLICATION OF
WAIQI
.
OF THE 56 PATIENTS TREATED,
41 COMPLETELY RECOVERED,
SHOWED SIGNIFICANT IMPROVEMENT, AND
SHOWED MODERATE IMPROVEMENT.
ONE OF THE PATIENTS,
HOWEVER, EXPERIENCED NO CHANGE IN CONDITION.
C.
(U)
TITLE - "EXAMPLE OF A CURE FOR LONG-TERM DYSURIA
RESULTING FROM TRAUMATIC SPINAL INJURY"
(QK,
NO.
9,
1990,
P.
28)
- RESEARCHERS AND AFFILIATION
--
((LIU))
RUITING (STC 0491 3843
1656)
OF THE CLINIC OF THE PLA AIR FORCE,
JINAN MR GENERAL
HEADQUARTERS, JINAN (GEOCOORD:3640N/ 11700E)
.
- CONTENT -
TREATMENT COMBINED BIOLOGICAL HOLOGRAPHIC
ACUPUNCTURE THERAPY (STC 3932 3670 0356
1873
6859
0459
4070 3127)
WITH THE APPLICATION OF WAIQI.
WAIQI WAS APPLIED FOR 10-20 MINUTES
TO THE LAOGONG XUEWEI AND ABDOMEN OF THE PATIENT, A
6 -YEAR-OLD
GIRL.
REMOTE WAIQI WAS APPLIED THE NEXT DAY AS WELL.
FOLLOWING
THE TREATMENT,
THE PATIENT WAS ABLE
TO ELIMINATE 300-500
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
PAGE: 0009
MILLILITERS OF URINE EVERY 2-3 HOURS UNASSISTED WITH NO RESIDUAL
URINE.
D.
(U)
TITLE - "TREATMENT OF STRESS HEADACHE WITH QIGONG
"
(ZQ,
NO.
5,
1990,
PP.
15-16)
- RESEARCHERS AND AFFILIATION
--
((GAO))
ZHENGJIN (STC 7559
2973 0093),
((LIU)
GUANGYOU (STC 0991 0392 0695), AND ((MING))
DEJUN
(STC 2999
1795 0193) OF THE 329TH PLA HOSPITAL,
CHONGQING
(GEOCOORD : 2939N/ 10635E)
.
- CONTENT -
THE CLINIC TREATED THE 28
STRESS HEADACHE
PATIENTS OF THE EXPERIMENTAL GROUP WITH QIGONG AND THE 33 PATIENTS
OF THE CONTROL GROUP WITH WESTERN MEDICINE.
THOSE
IN THE
EXPERIMENTAL GROUP HAD WAIQI APPLIED DIRECTLY TO THE AFFECTED
AREAS.
AFTER THE WAIQI TREATMENT,
PATIENTS WERE GIVEN MASSAGE
THERAPY.
THE CONTROL GROUP WAS GIVEN PAIN KILLERS,
SEDATIVES,
SLEEPING PILLS, AND VITAMIN
B TABLETS.
AFTER TEN DAYS OF
TREATMENT,
THE EXPERIMENTAL GROUP REPORTED
15 CASES OF COMPLETE
CURE,
CASES OF MARKED IMPROVEMENT,
5 CASES OF MODERATE
IMPROVEMENT, AND
1 CASE
IN WHICH THERE WAS NO CHANGE.
THE CONTROL
GROUP REPORTED
6 CASES OF COMPLETE CURE,
8 CASES OF MARKED
IMPROVEMENT,
CASES OF MODERATE IMPROVEMENT, AND
12 CASES OF NO
CHANGE.
9.
(U) QIGONG THERAPY EQUIPMENT
A.
(U) MODEL F2-A MULTIFUNCTIONAL QIGONG THERAPY EQUIPMENT
(JR,
10 APRIL
1991,
P.
3)
THIS EQUIPMENT WAS DEVELOPED AND MANUFACTURED BY THE JOINT
CHINA TIANHENG INTERNATIONAL ECONOMIC AND TECHNOLOGY TRADE COMPANY
(STC 0022 0998
1131 5899
0998 7139 9892 3999 2111 5890 6319 2996
0678 0155 9920 0361 0679)
(FIELD COMMENT - LOCATION UNKNOWN) UNDER
THE SUPERVISION OF THE BEIJING MR GENERAL HOSPITAL.
THE EQUIPMENT
PROBABLY WILL BE MARKETED COMMERCIALLY AFTER THE MANUFACTURER
OBTAINS PATENT RIGHTS TO THE EQUIPMENT.
THE EQUIPMENT
IS DESIGNED
TO GENERATE WAIQI THAT WILL FREE CLOGGED ENERGY CHANNELS, REDUCE
INFLAMMATION, AND RELIEVE PAIN.
THE EQUIPMENT
IS ALSO DESIGNED TO
FINE TUNE THE AUTONOMIC NERVOUS
SYSTEM AND THE IMMUNE SYSTEM.
IT
IS ESPECIALLY EFFECTIVE
IN TREATING ANGIITIS,
TUMORS, AND
PSEUDOMYOPIA.
IT CAN ALSO BE USED TO TREAT
100 TYPES OF DISEASES,
INCLUDING ARTHRITIS, HYPERTENSION, DIABETES, AND BRONCHITIS.
IT
WAS CLINICALLY FOUND TO BE EFFECTIVE
IN 96.6 PERCENT OF THE CASES
TREATED.
COMMENTS:
(FIELD COMMENTS)--l.
(U) BASED ON THE NUMBER OF
RESEARCH PROJECTS REPORTED,
THE BEIJING MR GENERAL HOSPITAL,
THE
BEIJING MR QIGONG INSTITUTE, AND THE PLA NAVY GENERAL HOSPITAL
APPEAR TO BE THE PRIMARY PLA ORGANIZATIONS
INVOLVED
IN QIGONG
RESEARCH.
THE LEADING RESEARCHERS AT THESE ORGANIZATIONS APPEAR TO
BE XU WUGE OF THE BEIJING MR GENERAL HOSPITAL, WAN SUJIAN OF THE
BEIJING MR QIGONG INSTITUTE, AND FENG LIDA OF THE PLA NAVY GENERAL
HOSPITAL.
2.
(U) WITH THE EXCLUSION OF PARAGRAPH 3-1,
THE EIGHT STUDIES
PERTAINING TO THE QIGONG MECHANISM CAN BE BROKEN DOWN AS FOLLOWS -
1)
SIX STUDIES RELATED TO QIGONG WAIQI,
THREE OF WHICH CONCERN THE
IN VITRO EFFECTS OF WAIQI RADIATION (PARA 2-A,
2-D,
2-F),
TWO
CONCERN THE
IN VIVO EFFECTS OF WAIQI RADIATION (PARA 2-B,
2-E), AND
ONE CONCERNS WAIQI FROM THE STANDPOINT OF THE QIGONG THERAPIST
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
PAGE: 0010
(PARA 2-C);
2)
TWO STUDIES CONCERNING THE EFFECTS QIGONG TRAINING
HAS ON THE PHYSICAL CONDITION OF QIGONG TRAINEES
(PARA 2-G,
2-H).
OVERALL, ONLY A SMALL NUMBER OF
IN VITRO STUDIES CONDUCTED CONCERN
QIGONG .
OF THE EIGHT STUDIES THAT USED HUMAN SUBJECTS,
TWO DEALT
WITH THE EFFECTS OF QIGONG ON THE PHAGOCYTOSIS OF HUMAN
LEUCOCYTES.
THE RESEARCH STRESSES THE AFFECT OF QIGONG ON THE
HUMAN IMMUNOLOGICAL
SYSTEM.
CONFIDENTIAL
Approved For Release 2003/09/09
: CIA-RDP96-00792R000200650008-7
SGI
A